• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艾滋病毒感染者或艾滋病患者的治疗与护理成本:欧洲标准化成本框架的制定

The treatment and care costs of people with HIV infection or AIDS: development of a standardised cost framework for Europe.

作者信息

Tolley K, Gyldmark M

机构信息

Centre for Health Economics, University of York, UK.

出版信息

Health Policy. 1993 Apr;24(1):55-70. doi: 10.1016/0168-8510(93)90088-7.

DOI:10.1016/0168-8510(93)90088-7
PMID:10125812
Abstract

A number of European studies have attempted to assess the treatment and care costs of people with HIV infection or AIDS. However, because of the different methods used, the various cost estimates produced are difficult to compare. This paper reviews several European HIV-AIDS costs studies and outlines the differences in methods used and where better approaches to cost estimation could have been adopted. The application of a standardised cost framework to new cost studies would improve the basis for making cost comparisons of models of care in different sites and countries and the identification of actual (rather than methodological) variations in costs across sites. The final part of the paper provides a discussion of the development and application of a standardised framework for assessment of the costs of HIV-AIDS treatment and care in Europe.

摘要

一些欧洲研究试图评估艾滋病毒感染者或艾滋病患者的治疗和护理成本。然而,由于所采用的方法不同,得出的各种成本估算难以进行比较。本文回顾了几项欧洲艾滋病毒/艾滋病成本研究,概述了所使用方法的差异以及在哪些方面本可采用更好的成本估算方法。将标准化成本框架应用于新的成本研究,将改善在不同地点和国家对护理模式进行成本比较的基础,并有助于识别各地点成本的实际(而非方法上的)差异。本文的最后一部分讨论了用于评估欧洲艾滋病毒/艾滋病治疗和护理成本的标准化框架的制定和应用。

相似文献

1
The treatment and care costs of people with HIV infection or AIDS: development of a standardised cost framework for Europe.艾滋病毒感染者或艾滋病患者的治疗与护理成本:欧洲标准化成本框架的制定
Health Policy. 1993 Apr;24(1):55-70. doi: 10.1016/0168-8510(93)90088-7.
2
Forecasting the medical care costs of the HIV epidemic.预测艾滋病流行的医疗费用。
Caring. 1992 Aug;11(8):52-3, 55-6, 58.
3
Preliminary cost-effectiveness analysis of an AIDS vaccine in Abidjan, Ivory Coast.科特迪瓦阿比让一种艾滋病疫苗的初步成本效益分析。
Health Policy. 1993 May;24(2):145-53. doi: 10.1016/0168-8510(93)90031-j.
4
Cost of care for Medicaid recipients with serious mental illness and HIV infection or AIDS.患有严重精神疾病且感染了艾滋病毒或患艾滋病的医疗补助受助者的护理费用。
Psychiatr Serv. 2003 Sep;54(9):1240-6. doi: 10.1176/appi.ps.54.9.1240.
5
Economic and demographic consequences of AIDS in Namibia: rapid assessment of the costs.纳米比亚艾滋病的经济和人口影响:成本快速评估
Int J Health Plann Manage. 1997 Oct-Dec;12(4):315-26. doi: 10.1002/(SICI)1099-1751(199710/12)12:4<315::AID-HPM492>3.0.CO;2-A.
6
Guidelines for rapid estimation of the direct and indirect costs of HIV infection in a developing country.发展中国家艾滋病毒感染直接和间接成本快速估算指南。
Health Policy. 1989;11(2):169-86. doi: 10.1016/0168-8510(89)90034-1.
7
Forecasting the medical care costs of the HIV epidemic: 1991-1994.预测艾滋病流行的医疗费用:1991 - 1994年
Inquiry. 1991 Fall;28(3):213-25.
8
How good are US studies of HIV costs of care?
Med Care. 1999 Aug;37(8):748-59. doi: 10.1097/00005650-199908000-00005.
9
The lifetime cost of treating a person with HIV.治疗一名艾滋病毒感染者的终身费用。
JAMA. 1993 Jul 28;270(4):474-8.
10
Econometric issues in modeling the costs of AIDS.
Health Policy. 1989;11(2):125-45. doi: 10.1016/0168-8510(89)90032-8.

引用本文的文献

1
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study.评估抗逆转录病毒疗法随时间推移的成本效益:一项队列研究和成本效益研究
Pharmacoecon Open. 2024 Nov;8(6):847-856. doi: 10.1007/s41669-024-00513-7. Epub 2024 Jul 30.
2
Lower healthcare costs associated with the use of a single-pill ARV regimen in the UK, 2004-2008.2004-2008 年英国使用单片抗逆转录病毒药物治疗方案降低了医疗保健费用。
PLoS One. 2012;7(10):e47376. doi: 10.1371/journal.pone.0047376. Epub 2012 Oct 30.
3
Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults.
新型药物和早期治疗:对艾滋病毒感染成年人终生护理费用的影响。
AIDS. 2012 Jan 2;26(1):45-56. doi: 10.1097/QAD.0b013e32834dce6e.
4
The Direct Medical Costs of Late Presentation (<350/mm) of HIV Infection over a 15-Year Period.15年期间HIV感染延迟就诊(<350/mm)的直接医疗费用。
AIDS Res Treat. 2012;2012:757135. doi: 10.1155/2012/757135. Epub 2011 Aug 29.
5
The impact of disease stage on direct medical costs of HIV management: a review of the international literature.疾病分期对艾滋病管理直接医疗费用的影响:国际文献回顾。
Pharmacoeconomics. 2010;28 Suppl 1:35-47. doi: 10.2165/11587430-000000000-00000.
6
Use and cost of antiretrovirals in France 1995-2000: an analysis based on the Medical Dossier on Human Immunodeficiency (release 2) database.1995 - 2000年法国抗逆转录病毒药物的使用与成本:基于人类免疫缺陷医学档案(第2版)数据库的分析
Pharmacoeconomics. 2004;22(16):1061-70. doi: 10.2165/00019053-200422160-00003.
7
The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001.1995 - 2001年期间,艾滋病病毒/艾滋病患者医疗护理直接成本的变化情况。
CMAJ. 2003 Jul 22;169(2):106-10.
8
The cost of HIV treatment and care. A global review.艾滋病毒治疗与护理的成本。一项全球综述。
Pharmacoeconomics. 2001 Jan;19(1):13-39. doi: 10.2165/00019053-200119010-00002.
9
Hospital care for persons with AIDS in European-Union countries; a cross-country comparison.欧盟国家艾滋病患者的住院护理;一项跨国比较。
Health Care Manag Sci. 2000 Jan;3(1):1-7. doi: 10.1023/a:1019064518010.
10
Health economics in HIV disease. A review of the European literature.艾滋病的健康经济学。欧洲文献综述。
Pharmacoeconomics. 1999;15 Suppl 1:1-12. doi: 10.2165/00019053-199915001-00001.